Abstract
Vulvovaginal symptoms are extremely common and result in millions of visits to practitioners' offices, STD clinics and emergency rooms. Vaginal infections or infectious vaginitis is responsible for only a minority of symptoms and is readily diagnosed. Epidemiology, diagnosis and therapy of vaginitis is reviewed.
MeSH terms
-
Adult
-
Animals
-
Anti-Infective Agents, Local / therapeutic use
-
Antifungal Agents / therapeutic use
-
Antitrichomonal Agents / therapeutic use
-
Atrophy
-
Candidiasis, Vulvovaginal / diagnosis
-
Candidiasis, Vulvovaginal / drug therapy
-
Clotrimazole / therapeutic use
-
Diagnosis, Differential
-
Dyspareunia / etiology
-
Female
-
Fluconazole / therapeutic use
-
Humans
-
Imidazoles / therapeutic use
-
Itraconazole / therapeutic use
-
Ketoconazole / therapeutic use
-
Male
-
Miconazole / therapeutic use
-
Middle Aged
-
Nystatin / therapeutic use
-
Ornidazole / therapeutic use
-
Pregnancy
-
Pregnancy Complications, Parasitic / diagnosis
-
Tinidazole / therapeutic use
-
Triazoles / therapeutic use
-
Trichomonas Vaginitis / diagnosis
-
Trichomonas Vaginitis / drug therapy
-
Trichomonas Vaginitis / transmission
-
Vaginitis / diagnosis
-
Vaginosis, Bacterial / diagnosis
-
Vaginosis, Bacterial / drug therapy
-
Vulvovaginitis* / diagnosis
-
Vulvovaginitis* / drug therapy
Substances
-
Anti-Infective Agents, Local
-
Antifungal Agents
-
Antitrichomonal Agents
-
Imidazoles
-
Triazoles
-
Tinidazole
-
terconazole
-
Nystatin
-
Itraconazole
-
Ornidazole
-
Miconazole
-
Fluconazole
-
Clotrimazole
-
Ketoconazole
-
tioconazole